Phase II study of cabozantinib in patients with MET-altered lung cancers Meeting Abstract
| Authors: | Harada, G.; Santini, F. C.; Repetti, R. W.; Chang, J.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Wilhelm, C. J.; Goldstein, M.; Makhnin, A.; Ginsberg, M. S.; Plodkowski, A. J.; Kris, M. G.; Drilon, A. |
| Abstract Title: | Phase II study of cabozantinib in patients with MET-altered lung cancers |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S794 |
| Language: | English |
| ACCESSION: | WOS:001087480202062 |
| DOI: | 10.1016/j.annonc.2023.09.2417 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1384P -- Source: Wos |
